Clinical use of the new macrolides, azalides, and streptogramins in pediatrics.

J Chemother

Children's Hospital, University of Munich, Germany.

Published: December 1992

Macrolides are the primary drugs of choice for a number of clinically significant infections in children. The clinical aspects of newer macrolides such as roxithromycin, clarithromycin, dirithromycin, flurithromycin, miocamycin, rokitamycin, azithromycin and RP 59500 are discussed in different pediatric infections including streptococcal infections (e.g. pharyngitis, otitis, pneumonia, skin infections), staphylococcus soft tissue infections, mycoplasma pneumonia, chlamydial infections as well as legionellosis and campylobacter enteritis. Also, incidences of adverse events in pediatric patients receiving different macrolides are indicated as well as the dosages in children. The advantages of newer macrolides are: lower dosages, b.i.d. or once daily dosage regimens, good intracellular and tissue penetration, better activity against gram-negative microorganisms (some) and a low rate of adverse reactions.

Download full-text PDF

Source
http://dx.doi.org/10.1080/1120009x.1992.11739194DOI Listing

Publication Analysis

Top Keywords

newer macrolides
8
infections
6
clinical macrolides
4
macrolides azalides
4
azalides streptogramins
4
streptogramins pediatrics
4
macrolides
4
pediatrics macrolides
4
macrolides primary
4
primary drugs
4

Similar Publications

Antimicrobial Susceptibility of to Macrolides and Characterization of (T)-Carrying Mobile Elements on Chromosome.

Animals (Basel)

January 2025

National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou 510642, China.

is the etiological agent of Glässer's disease, which causes high morbidity and mortality in pigs worldwide. Macrolide resistance poses an urgent threat to their treatment, as macrolides are widely used for preventing and treating infections. Here, we determined the susceptibilities to five macrolides and characterized the genetic markers of macrolide resistance.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines the adverse events (AEs) linked to clarithromycin, an antibiotic, across different age groups using data from the FDA Adverse Event Reporting System (FAERS).
  • Common AEs include vomiting and diarrhea in younger age groups, while older adults experience issues like abnormal taste and drug interactions.
  • Eighteen age-specific signals were identified, highlighting the need for tailored monitoring and management of clarithromycin's safety profile in different age demographics.
View Article and Find Full Text PDF

Mastitis is a globally prevalent bacterial disease of lactating cows. Prevention and control of this multi-etiological complex disease relies upon administration of antibiotics. This has led to the emergence of newer multi-drug resistant strains.

View Article and Find Full Text PDF

Evolving treatment strategies for early-life seizures in Tuberous Sclerosis Complex: A review and treatment algorithm.

Epilepsy Behav

December 2024

Division of Child Neurology, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address:

Tuberous sclerosis Complex (TSC) is a genetic disorder characterized by multisystem involvement, with epilepsy affecting 80-90% of patients, often beginning in infancy. Early-life seizures in TSC are associated with poor neurodevelopmental outcomes, underscoring the importance of timely and effective management. This review explores the evolving treatment landscape for TSC-associated seizures in young children, focusing on three recently approved or license-expanded therapies: vigabatrin, everolimus, and cannabidiol.

View Article and Find Full Text PDF
Article Synopsis
  • The IDEOM Vitiligo Workgroup aims to create a standardized approach for reporting the severity of vitiligo, as current methods are inconsistent and lack uniformity.
  • A literature review identified 50 clinical trials focusing on topical treatments for vitiligo, revealing various grading systems for measuring repigmentation and quality of life.
  • The study suggests employing metrics like body surface area scoring and the Vitiligo Area Scoring Index to improve data collection, while also considering new factors like treatment burden and cost-effectiveness.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!